IL-17 May Be a Key Cytokine Linking Psoriasis and Hyperglycemia

Psoriasis is associated with the metabolic syndrome, an interconnected group of conditions characterized by significant morbidity and mortality, although the causal mechanisms are still under investigation. Ikumi et al. provide evidence of a link—involving IL-17—between psoriasis and hyperglycemia i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of investigative dermatology 2019-06, Vol.139 (6), p.1214-1216
Hauptverfasser:	Gardner, Louis C.S., Grantham, Henry J., Reynolds, Nick J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Cytokines Humans Hyperglycemia Inflammation Interleukin-17 Mice Psoriasis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	1216
container_issue	6
container_start_page	1214
container_title	Journal of investigative dermatology
container_volume	139
creator	Gardner, Louis C.S. Grantham, Henry J. Reynolds, Nick J.
description	Psoriasis is associated with the metabolic syndrome, an interconnected group of conditions characterized by significant morbidity and mortality, although the causal mechanisms are still under investigation. Ikumi et al. provide evidence of a link—involving IL-17—between psoriasis and hyperglycemia in humans and mice.
doi_str_mv	10.1016/j.jid.2019.02.038
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2232084785</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022202X19314824</els_id><sourcerecordid>2232084785</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-ad96c5f5d00f577728f4274d5bf9a6fc8914aa3175f5a3b357e58f2230eae9b03</originalsourceid><addsrcrecordid>eNp9kD1PwzAURS0EoqXwA1iQR5YEf8RxIgYEFdCKIBhAYrNc56VyaJJip0j597hqYWS6y7n36R2EzimJKaHpVR3XtowZoXlMWEx4doDGVDAeUZnIQzQmhLGIEfYxQife1yR0EpEdoxGnlKUJk2N0My8CjZ_1gO8Aa_wEA54OffdpW8CFbUMu8avvnNXeeqzbEs-GNbjlajDQWH2Kjiq98nC2zwl6f7h_m86i4uVxPr0tIsPztI90madGVKIkpBJSSpZV4XxSikWV67QyWU4TrTmVgdF8wYUEkVWMcQIa8gXhE3S521277msDvleN9QZWK91Ct_EqoIxkicxEQOkONa7z3kGl1s422g2KErX1pmoVvKmtN0WYCt5C52I_v1k0UP41fkUF4HoHQHjy24JT3lhoDZTWgelV2dl_5n8AXi57ZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2232084785</pqid></control><display><type>article</type><title>IL-17 May Be a Key Cytokine Linking Psoriasis and Hyperglycemia</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Gardner, Louis C.S. ; Grantham, Henry J. ; Reynolds, Nick J.</creator><creatorcontrib>Gardner, Louis C.S. ; Grantham, Henry J. ; Reynolds, Nick J.</creatorcontrib><description>Psoriasis is associated with the metabolic syndrome, an interconnected group of conditions characterized by significant morbidity and mortality, although the causal mechanisms are still under investigation. Ikumi et al. provide evidence of a link—involving IL-17—between psoriasis and hyperglycemia in humans and mice.</description><identifier>ISSN: 0022-202X</identifier><identifier>EISSN: 1523-1747</identifier><identifier>DOI: 10.1016/j.jid.2019.02.038</identifier><identifier>PMID: 31126427</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cytokines ; Humans ; Hyperglycemia ; Inflammation ; Interleukin-17 ; Mice ; Psoriasis</subject><ispartof>Journal of investigative dermatology, 2019-06, Vol.139 (6), p.1214-1216</ispartof><rights>2019 The Authors</rights><rights>Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-ad96c5f5d00f577728f4274d5bf9a6fc8914aa3175f5a3b357e58f2230eae9b03</citedby><cites>FETCH-LOGICAL-c396t-ad96c5f5d00f577728f4274d5bf9a6fc8914aa3175f5a3b357e58f2230eae9b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31126427$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gardner, Louis C.S.</creatorcontrib><creatorcontrib>Grantham, Henry J.</creatorcontrib><creatorcontrib>Reynolds, Nick J.</creatorcontrib><title>IL-17 May Be a Key Cytokine Linking Psoriasis and Hyperglycemia</title><title>Journal of investigative dermatology</title><addtitle>J Invest Dermatol</addtitle><description>Psoriasis is associated with the metabolic syndrome, an interconnected group of conditions characterized by significant morbidity and mortality, although the causal mechanisms are still under investigation. Ikumi et al. provide evidence of a link—involving IL-17—between psoriasis and hyperglycemia in humans and mice.</description><subject>Animals</subject><subject>Cytokines</subject><subject>Humans</subject><subject>Hyperglycemia</subject><subject>Inflammation</subject><subject>Interleukin-17</subject><subject>Mice</subject><subject>Psoriasis</subject><issn>0022-202X</issn><issn>1523-1747</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAURS0EoqXwA1iQR5YEf8RxIgYEFdCKIBhAYrNc56VyaJJip0j597hqYWS6y7n36R2EzimJKaHpVR3XtowZoXlMWEx4doDGVDAeUZnIQzQmhLGIEfYxQife1yR0EpEdoxGnlKUJk2N0My8CjZ_1gO8Aa_wEA54OffdpW8CFbUMu8avvnNXeeqzbEs-GNbjlajDQWH2Kjiq98nC2zwl6f7h_m86i4uVxPr0tIsPztI90madGVKIkpBJSSpZV4XxSikWV67QyWU4TrTmVgdF8wYUEkVWMcQIa8gXhE3S521277msDvleN9QZWK91Ct_EqoIxkicxEQOkONa7z3kGl1s422g2KErX1pmoVvKmtN0WYCt5C52I_v1k0UP41fkUF4HoHQHjy24JT3lhoDZTWgelV2dl_5n8AXi57ZQ</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Gardner, Louis C.S.</creator><creator>Grantham, Henry J.</creator><creator>Reynolds, Nick J.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201906</creationdate><title>IL-17 May Be a Key Cytokine Linking Psoriasis and Hyperglycemia</title><author>Gardner, Louis C.S. ; Grantham, Henry J. ; Reynolds, Nick J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-ad96c5f5d00f577728f4274d5bf9a6fc8914aa3175f5a3b357e58f2230eae9b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Cytokines</topic><topic>Humans</topic><topic>Hyperglycemia</topic><topic>Inflammation</topic><topic>Interleukin-17</topic><topic>Mice</topic><topic>Psoriasis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gardner, Louis C.S.</creatorcontrib><creatorcontrib>Grantham, Henry J.</creatorcontrib><creatorcontrib>Reynolds, Nick J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of investigative dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gardner, Louis C.S.</au><au>Grantham, Henry J.</au><au>Reynolds, Nick J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IL-17 May Be a Key Cytokine Linking Psoriasis and Hyperglycemia</atitle><jtitle>Journal of investigative dermatology</jtitle><addtitle>J Invest Dermatol</addtitle><date>2019-06</date><risdate>2019</risdate><volume>139</volume><issue>6</issue><spage>1214</spage><epage>1216</epage><pages>1214-1216</pages><issn>0022-202X</issn><eissn>1523-1747</eissn><abstract>Psoriasis is associated with the metabolic syndrome, an interconnected group of conditions characterized by significant morbidity and mortality, although the causal mechanisms are still under investigation. Ikumi et al. provide evidence of a link—involving IL-17—between psoriasis and hyperglycemia in humans and mice.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31126427</pmid><doi>10.1016/j.jid.2019.02.038</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0022-202X
ispartof	Journal of investigative dermatology, 2019-06, Vol.139 (6), p.1214-1216
issn	0022-202X 1523-1747
language	eng
recordid	cdi_proquest_miscellaneous_2232084785
source	MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects	Animals Cytokines Humans Hyperglycemia Inflammation Interleukin-17 Mice Psoriasis
title	IL-17 May Be a Key Cytokine Linking Psoriasis and Hyperglycemia
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T12%3A49%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IL-17%20May%20Be%20a%20Key%20Cytokine%20Linking%20Psoriasis%20and%20Hyperglycemia&rft.jtitle=Journal%20of%20investigative%20dermatology&rft.au=Gardner,%20Louis%20C.S.&rft.date=2019-06&rft.volume=139&rft.issue=6&rft.spage=1214&rft.epage=1216&rft.pages=1214-1216&rft.issn=0022-202X&rft.eissn=1523-1747&rft_id=info:doi/10.1016/j.jid.2019.02.038&rft_dat=%3Cproquest_cross%3E2232084785%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2232084785&rft_id=info:pmid/31126427&rft_els_id=S0022202X19314824&rfr_iscdi=true